Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

Lais Osmani(Johns Hopkins University), Frederic B. Askin(Johns Hopkins University), Edward Gabrielson(Johns Hopkins University), Qing Kay Li(Johns Hopkins University)
Seminars in Cancer Biology
November 26, 2017
10.1016/j.semcancer.2017.11.019
Cited by 825Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis